WallStSmart

Unusual Machines, Inc. (UMAC)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 2212% more annual revenue ($258.90M vs $11.20M). ZEPP leads profitability with a -15.5% profit margin vs -171.4%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

UMAC

Avoid

28

out of 100

Grade: F

Growth: 6.3Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: -0.30

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for UMAC.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

UMAC3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
144.4%10/10

Revenue surging 144.4% year-over-year

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

UMAC4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$692.44M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-20.2%2/10

ROE of -20.2% — below average capital efficiency

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : UMAC

The strongest argument for UMAC centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 144.4% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : UMAC

The primary concerns for UMAC are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

UMAC carries more volatility with a beta of 19.89 — expect wider price swings.

UMAC is growing revenue faster at 144.4% — sustainability is the question.

Monitor COMPUTER HARDWARE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 28/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Unusual Machines, Inc.

TECHNOLOGY · COMPUTER HARDWARE · USA

Unusual Machines, Inc. (UMAC) is an innovative leader in the automation and manufacturing technology sector, dedicated to enhancing operational efficiency through state-of-the-art robotics and artificial intelligence solutions. The company focuses on optimizing production processes, which not only drives productivity but also delivers significant cost savings for its clients. Committed to sustainability, UMAC integrates eco-friendly practices into its operations, transforming traditional manufacturing methods. With ongoing efforts to establish strategic partnerships and expand its market footprint, UMAC is poised for robust growth and long-term value creation for its shareholders.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?